Glycan News and Research

RSS
Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

Potent antibody with a novel neutralization mechanism against SARS-CoV-2 variants

A full model of the SARS-CoV-2 spike protein for studying its atomic-level dynamics by multiple microsecond simulations

A full model of the SARS-CoV-2 spike protein for studying its atomic-level dynamics by multiple microsecond simulations

Artificial intelligence-based computational program predicts the 3D structure of rotavirus spike protein

Artificial intelligence-based computational program predicts the 3D structure of rotavirus spike protein

MIT researchers identify components of mucus that can inhibit fungal infections

MIT researchers identify components of mucus that can inhibit fungal infections

The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

SARS-CoV-2 variants BA.4 and BA.5 show substantial immune escape compared with BA.1 and BA.2

SARS-CoV-2 variants BA.4 and BA.5 show substantial immune escape compared with BA.1 and BA.2

A sugar-studded protein could be key to stopping Alzheimer’s disease progression, finds study

A sugar-studded protein could be key to stopping Alzheimer’s disease progression, finds study

Researchers explore broad-based immunity against potentially pandemic-causing viruses

Researchers explore broad-based immunity against potentially pandemic-causing viruses

Infection with SARS-CoV-2 results in antibodies against common colds

Infection with SARS-CoV-2 results in antibodies against common colds

Researchers investigate O-glycosylation in cells infected with Ebola

Researchers investigate O-glycosylation in cells infected with Ebola

Study investigates the production of a virosome-based COVID-19 vaccine candidate

Study investigates the production of a virosome-based COVID-19 vaccine candidate

Ultralong bovine antibody targets cryptic and conserved epitope on SARS-CoV and SARS-CoV-2

Ultralong bovine antibody targets cryptic and conserved epitope on SARS-CoV and SARS-CoV-2

Challenges, unmet needs and future opportunities in COVID-19 therapeutics

Challenges, unmet needs and future opportunities in COVID-19 therapeutics

Therapeutic antibodies against filoviruses including Ebola and Marburg

Therapeutic antibodies against filoviruses including Ebola and Marburg

MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

MERS-CoV-related viruses invade host cells via bat angiotensin-converting enzyme 2 receptors

IgG Fc glycosylation: A marker for severe COVID-19

IgG Fc glycosylation: A marker for severe COVID-19

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Study finds fractionation of sulfated galactan from red alga can isolate its anti-SARS-CoV-2 properties

Conformational variation of the SARS-CoV-2 energy landscape

Conformational variation of the SARS-CoV-2 energy landscape

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.